We are very pleased to announce that Clément Linger has been awarded the SFGBM (Société Française de Génie Biologique et Médical) Innovation Prize for his work entitled:
“Quantitative Photoacoustic Characterization of Theranostic Nanoparticles: Towards 3D Imaging of Their Accumulation in Rheumatoid Arthritis”,
carried out under the joint supervision of the Laboratory of Biomedical Imaging and the Institut Galien Paris-Saclay.

This prize was awarded following a vote by the SFGBM members, after the finalists presented their work at the SFGBM General Assembly, held on June 20, 2025, at the Institut des Nanotechnologies de Lyon (INL), Université Lyon 1, in Villeurbanne.

Congratulations to Clément for this well-deserved recognition of the quality and impact of his work!